Overview

Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the efficacy of metformin for treatment antipsychotic-induced metabolic syndrome in bipolar disorder patients.
Phase:
Phase 4
Details
Lead Sponsor:
China Medical University, China
Treatments:
Antipsychotic Agents
Metformin